MXPA04011018A - Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias. - Google Patents

Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias.

Info

Publication number
MXPA04011018A
MXPA04011018A MXPA04011018A MXPA04011018A MXPA04011018A MX PA04011018 A MXPA04011018 A MX PA04011018A MX PA04011018 A MXPA04011018 A MX PA04011018A MX PA04011018 A MXPA04011018 A MX PA04011018A MX PA04011018 A MXPA04011018 A MX PA04011018A
Authority
MX
Mexico
Prior art keywords
airway
proton pump
therapeutics
pump inhibitors
new combination
Prior art date
Application number
MXPA04011018A
Other languages
English (en)
Inventor
Kromer Wolfgang
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of MXPA04011018A publication Critical patent/MXPA04011018A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invencion se refiere a la combinacion de inhibidores de la bomba protonica reversibles y terapeuticos de las vias respiratorias para el tratamiento de trastornos de las vias respiratorias.
MXPA04011018A 2002-05-07 2003-05-03 Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias. MXPA04011018A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02010305 2002-05-07
PCT/EP2003/004653 WO2003094967A2 (en) 2002-05-07 2003-05-03 New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders

Publications (1)

Publication Number Publication Date
MXPA04011018A true MXPA04011018A (es) 2005-01-25

Family

ID=29414673

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04011018A MXPA04011018A (es) 2002-05-07 2003-05-03 Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias.

Country Status (17)

Country Link
US (1) US20050222193A1 (es)
EP (1) EP1506016A2 (es)
JP (1) JP2005528418A (es)
KR (1) KR20050007476A (es)
CN (1) CN1652822A (es)
AU (1) AU2003227710A1 (es)
BR (1) BR0309808A (es)
CA (1) CA2484272A1 (es)
EA (1) EA200401454A1 (es)
HR (1) HRP20041160A2 (es)
IL (1) IL164755A0 (es)
MX (1) MXPA04011018A (es)
NO (1) NO20045343L (es)
PL (1) PL373287A1 (es)
RS (1) RS95304A (es)
WO (1) WO2003094967A2 (es)
ZA (1) ZA200407896B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002342917A1 (en) * 2001-11-19 2003-06-10 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
WO2005104925A1 (en) * 2004-04-30 2005-11-10 Altana Pharma Ag Method of classifying gerd
WO2006037766A1 (en) * 2004-10-05 2006-04-13 Altana Pharma Ag Oral pharmaceutical preparation comprising a proton pump antagonist and a basic excipient
CA2818336C (en) 2010-11-16 2018-04-24 Texas Heart Institute Agonists that enhance binding of integrin-expressing cells to integrin receptors
KR101873530B1 (ko) * 2012-04-10 2018-07-02 삼성전자주식회사 모바일 기기, 모바일 기기의 입력 처리 방법, 및 모바일 기기를 이용한 전자 결제 방법
JO3737B1 (ar) * 2015-07-21 2021-01-31 Athenex Therapeutics Ltd تركيبات علاجية من باكليتاكسيل تعطى عن طريق الفم ومثبط P-gp لعلاج السرطان

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
CA2165192C (en) * 1993-07-02 2001-04-24 Hermann Amschler Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors
DE19541689A1 (de) * 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
PL184060B1 (pl) * 1995-01-27 2002-08-30 Rhone Poulenc Rorer Ltd Podstawione związki fenylowe do zastosowania jako środki antagonistyczne endoteliny
DE69635048T2 (de) * 1995-06-12 2006-02-16 G.D. Searle & Co. Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
AU7095296A (en) * 1995-09-26 1997-04-17 Takeda Chemical Industries Ltd. Phosphorylamides, their preparation and use
US6599927B2 (en) * 1996-10-11 2003-07-29 Astrazeneca Ab Use of an H+, K+-ATPase inhibitor in the treatment of Widal's Syndrome
SE9603725D0 (sv) * 1996-10-11 1996-10-11 Astra Ab New teatment
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
ATE281178T1 (de) * 1997-07-25 2004-11-15 Altana Pharma Ag Protonenpumpenhemmer als kombinationstherapeutika mit antibakterielle wirkenden substanzen
US6060472A (en) * 1998-04-06 2000-05-09 Apotex Inc. Thiadiazole compounds useful as inhibitors of H+ /K+ atpase
NZ527232A (en) * 1998-08-26 2005-03-24 Smithkline Beecham Corp A composition contaning a PDE 4 inhibitor and a beta adrenergic bronchodilator useful for treating pulmonary diseases
US6436953B1 (en) * 1998-09-23 2002-08-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyridoethers
GB9911017D0 (en) * 1999-05-13 1999-07-14 Zeneca Ltd Pharmaceutical compositions
EP1313740B1 (en) * 2000-03-29 2005-11-30 ALTANA Pharma AG Prodrugs of imidazopyridine derivatives
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
CA2427814C (en) * 2000-11-07 2009-06-02 Merck & Co., Inc. A combination of a pde4 inhibitor and a leukotriene antagonist in the treatment of bronchial and respiratory disorders
AU2002342917A1 (en) * 2001-11-19 2003-06-10 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders

Also Published As

Publication number Publication date
US20050222193A1 (en) 2005-10-06
HRP20041160A2 (en) 2005-08-31
CN1652822A (zh) 2005-08-10
KR20050007476A (ko) 2005-01-18
RS95304A (en) 2006-12-15
AU2003227710A1 (en) 2003-11-11
BR0309808A (pt) 2005-03-01
ZA200407896B (en) 2006-06-28
EA200401454A1 (ru) 2005-06-30
JP2005528418A (ja) 2005-09-22
EP1506016A2 (en) 2005-02-16
NO20045343L (no) 2004-12-06
IL164755A0 (en) 2005-12-18
PL373287A1 (en) 2005-08-22
WO2003094967A2 (en) 2003-11-20
WO2003094967A3 (en) 2004-04-01
CA2484272A1 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
MY151032A (en) Treatment of tnf? related disorders
AP1913A (en) Substituted benzazoles and use thereof as raf kinase inhibitors
IL182417A0 (en) Mitotic kinesin inhibitors and methods of use thereof
MX349188B (es) Sns - 595 y metodos para utilizar el mismo.
NZ515567A (en) Method for treating chronic pain using MEK inhibitors
RS20050070A (en) Use of 1kb kinase inhibitors for the treatment of pain
TW200509937A (en) Novel compounds and their use in therapy
TNSN04015A1 (en) Combination therapy for the treatment of cancer
MXPA05004621A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes.
TW200716153A (en) Mitotic kinesin inhibitors and methods of use thereof
MXPA04011018A (es) Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias.
WO2004098599A3 (en) Proton pump inhibitors for the treatment of lower abdominal disorders
TW200603792A (en) Monotherapy for the treatment of psoriasis with cyclooxygenase-2 selective inhibitors
RS95204A (en) Combination for the treatment of airway disorders
NO20073610L (no) Nye substituerte tiofenpyrimidinonderivater som inhibitorer for 17 β-hydroksysteroiddehydrogenase
AU2002347984A1 (en) Use of norepinephrine reuptake inhibitors for the treatment of tic disorders
GB0411180D0 (en) Treatment of ballast water
WO2003043614A3 (en) Reversible proton pump inhibitors for the treatment of airway disorders
TW200603791A (en) Compounds and compositions as cathepsin S inhibitors
WO2003075926A8 (en) Use of proton pump inhibitors for the treatment of airway disorders
TW200508196A (en) Hydroxamic acids useful in the treatment of hyper-proliferative disorders
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen
IL164356A0 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
AU2003282035A1 (en) Modulation of s6 kinase activity for the treatment of obestiy
TW200510447A (en) Novel fusidic acid derivatives